Key statistics dashboard for NEXGEL, Inc. (NXGL). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations.
Stock Data
| Price | $0.25 |
| Market Cap | $2M |
| Beta | 0.85 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.40 |
| Price / Book | 0.51 |
| P/S | 0.20 |
| P/FCF | -0.73 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 35.07% |
| EBIT Margin | -31.34% |
| EBITDA Margin | -17.51% |
| Operating Margin | -44.77% |
| Net Margin | -51.26% |
Financial Health
| Current Ratio | 0.43 |
| Quick Ratio | 0.27 |
| Cash Ratio | 0.03 |
| Debt / Equity | 1.51 |
| Debt / Assets | 28.20% |
| Interest Coverage | -2.47 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -1.25 |
Per-Share Data
| Revenue per share | 1.34 |
| Book Value per share | 0.61 |
| Cash per share | 0.05 |
| FCF per share | -0.36 |
| Tangible Book Value per share | -1.02 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Related companies: ENLV · FEMY · GDTC · HBIO · IINN · MLSS · MTVA
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of NXGL: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks